Acute myeloid leukaemia with cup-like nuclei associated with t(9;22)(q34;q11.2)
Visceral leishmaniasis with haemophagocytic lymphohistiocytosis: the importance of scrutinising your samples
Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation
MicroRNAs in myeloid malignancies
The current role of T cell depletion in paediatric stem cell transplantation
A phase I first-in-human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077
TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study
Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group
Prevention of acute graft-versus-host disease by humanized anti-CD26 monoclonal antibody
Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations
Cerebrospinal fluid penetrance of lenalidomide in meningeal myeloma
High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
Proliferation of PTEN-deficient haematopoietic tumour cells is not affected by isoform-selective inhibition of p110β PI3-kinase and requires blockade of all class 1 PI3K activity
Neoplasms and infections as the main causes of death in patients in complete response to HIV-related non-Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients
Clinical and Laboratory Haemostasis 2013 3–4 September 2013, Sheffield Hallam University, Sheffield, UK